Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 19/20 | 0.77 |
| ▸ | PLA2G1B | P04054 | 6/20 | 0.73 |
| ▸ | PLA2G10 | O15496 | 6/20 | 0.73 |
| ▸ | PLA2G2E | Q9NZK7 | 6/20 | 0.73 |
| ▸ | PLA2G5 | P39877 | 5/20 | 0.73 |
| ▸ | PLA2G2F | Q9BZM2 | 4/20 | 0.73 |
| ▸ | PLA2G2D | Q9UNK4 | 4/20 | 0.73 |
| ▸ | PLA2G6 | O60733 | 1/20 | 0.73 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.73 |
| ▸ | PLA2G12B | Q9BX93 | 1/20 | 0.73 |
| ▸ | PLA2G12A | Q9BZM1 | 1/20 | 0.73 |
| ▸ | PLA2G3 | Q9NZ20 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2164905 | 0.91 | PLA2G2A (0.74) | PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5 | |
| SCHEMBL2157246 | 0.90 | PLA2G2A (0.80) | PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5 | |
| SCHEMBL7112890 | 0.89 | PLA2G2A (0.79) | PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5 | |
| SCHEMBL2165769 | 0.88 | PLA2G2A (0.75) | PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5 | |
| SCHEMBL7691296 | 0.88 | PLA2G2A (0.77) | PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5 | |
| SCHEMBL7962736 | 0.87 | PLA2G2A (1.00) | PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5 | |
| SCHEMBL8625284 | 0.87 | PLA2G2A (0.75) | PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5 | |
| Varespladib SCHEMBL29358982 | 0.84 | PLA2G2A (1.00) | PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5 | |
| Varespladib SCHEMBL26726 | 0.84 | PLA2G2A (1.00) | PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5 | |
| SCHEMBL2174774 | 0.83 | PLA2G2A (0.74) | PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007110230-A2 | SECRETED PROTEINS AS EARLY MARKERS AND DRUG TARGETS FOR AUTOIMMUNITY, TUMORIGENESIS AND INFECTIONS | INSTITUT PASTEUR (FR) | 2007-10-04 | — | — | WO | disclosed |
| EP-1840573-A1 | Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections | INSTITUT PASTEUR (FR) | 2007-10-03 | — | — | EP | disclosed |
| EP-1181276-A1 | MORPHOLINO-N-ETHYL ESTER DERIVATIVE OF AN INDOLE SPLA-2 INHIBITOR | ELI LILLY AND COMPANY (US) | 2002-02-27 | — | — | EP | disclosed |
| WO-2001066111-A1 | COMPOSITIONS CONTAINING POTENTIAL SPLA2 INHIBITORS FOR THE TREATMENT OF PAIN | ELI LILLY AND COMPANY (US) | 2001-09-13 | — | — | WO | disclosed |
| CN-1299277-A | Pharmaceutical composition containing phospholipase inhibitor sodium [ 3- (2-amino-1, 2-dioxyethyl) -2-ethyl-1 (benzyl) -1H-indol-4-yl ] oxy ] acetate | SHIONOGI & CO (JP) | 2001-06-13 | — | — | CN | disclosed |
| EP-1058547-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING THE PHOSPHOLIPASE INHIBITOR SODIUM 3-(2-AMINO-1,2-DIOXOETHYL)-2-ETHYL-1-PHENYLMETHYL)-1H-INDOL-4-YL]OXY]ACETATE | Shionogi & Co., Ltd. (JP) | 2000-12-13 | — | — | EP | disclosed |
| EP-1007046-A4 | METHOD FOR TREATMENT OF CHRONIC BRONCHITIS | LILLY CO ELI (US) | 2000-11-29 | — | — | EP | disclosed |
| WO-2000069818-A1 | MORPHOLINO-N-ETHYL ESTER DERIVATIVE OF AN INDOLE sPLA2 INHIBITOR | ELI LILLY AND COMPANY (US) | 2000-11-23 | — | — | WO | disclosed |
| EP-1039901-A1 | TREATMENT FOR ALZHEIMER'S DISEASE | ELI LILLY AND COMPANY (US) | 2000-10-04 | — | — | EP | disclosed |
| EP-1007046-A1 | 1H-INDOLE-3-GLYOXYLAMIDES FOR THE TREATMENT OF CHRONIC BRONCHITIS | ELI LILLY AND COMPANY (US) | 2000-06-14 | — | — | EP | disclosed |
| EP-1007056-A1 | METHOD FOR THE TREATMENT OF CYSTIC FIBROSIS | ELI LILLY AND COMPANY (US) | 2000-06-14 | — | — | EP | disclosed |
| WO-1999044604-A9 | PHARMACEUTICAL COMPOSITIONS CONTAINING THE PHOSPHOLIPASE INHIBITOR SODIUM [[3-(2-AMINO-1,2-DIOXOETHYL)-2-ETHYL-1-PHENYLMETHYL)-1H-INDOL-4-YL]OXY]ACETATE | SHIONOGI & CO (JP) | 2000-01-20 | — | — | WO | disclosed |
| WO-1999044604-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING THE PHOSPHOLIPASE INHIBITOR SODIUM [[3-(2-AMINO-1,2-DIOXOETHYL)-2-ETHYL-1-PHENYLMETHYL)-1H-INDOL-4-YL]OXY]ACETATE | SHIONOGI & CO., LTD. (JP) | 1999-09-10 | — | — | WO | disclosed |
| WO-1999025339-A1 | TREATMENT FOR ALZHEIMER'S DISEASE | ELI LILLY AND COMPANY (US) | 1999-05-27 | — | — | WO | disclosed |
| WO-1999016453-A1 | METHOD FOR THE TREATMENT OF CYSTIC FIBROSIS | ELI LILLY AND COMPANY (US) | 1999-04-08 | — | — | WO | disclosed |
| WO-1998042343-A1 | METHOD FOR TREATMENT OF CHRONIC BRONCHITIS | ELI LILLY AND COMPANY (US) | 1998-10-01 | — | — | WO | disclosed |